Nice, France

Neil Astles

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Isp Investments Inc.. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Neil Astles Revolutionizing Skin Protection

Introduction: Neil Astles, a talented inventor based in Nice, France, has made significant contributions to the field of skincare with his groundbreaking patent focused on protecting skin from cold thermal stress.

Latest Patents: Neil Astles holds a remarkable patent for methods of safeguarding skin from damage caused by cold thermal stress. His innovative approach involves topically applying a unique composition, including an extract from rehydrated cysts, to skin at risk of thermal stress-related harm. This composition is designed to provide optimal protection against cold temperature exposure and repeated fluctuations.

Career Highlights: Neil Astles currently shines as a key member of Isp Investments Inc., a renowned company at the forefront of skincare innovation. His expertise and dedication have played a pivotal role in advancing the development of novel solutions for skin protection and rejuvenation.

Collaborations: Throughout his illustrious career, Neil Astles has collaborated closely with esteemed colleagues such as Jean-Marie Botto and Valère Busuttil. Together, they have formed a dynamic team dedicated to pushing the boundaries of skincare science and delivering cutting-edge products to consumers worldwide.

Conclusion: In conclusion, Neil Astles stands out as a visionary inventor who continues to inspire and shape the future of skincare technology. His pioneering work in protecting skin from thermal stress serves as a testament to his ingenuity and commitment to excellence in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…